1. Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, P.R. China 2. Department of Otolaryngology Head and Neck Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan,410011, P.R. China 3. International College, Guangdong University of Foreign Studies, Guangzhou, Guangdong, 510420, P.R. China
✉ Corresponding authors: Pengfei Zhang, M.D., Ph.D., Professor and Vice Director, Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, Changsha, Hunan, China. Tel: 86-731-84327239; Fax: 86-731-84327608; E-mail: zhangpf690421edu.cn and Xin-ming Yang, M.D., Professor and Director, Department of Otolaryngology Head and Neck Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. Tel.: +86-(0)731-84213972; Fax: +86-(0)731-85533525; E-mail:x16y2013comMore
Citation:
Li Xx, liang Xj, Zhou Ly, Liu Rj, Bi W, Zhang S, Li Ss, Yang Wh, Chen Zc, Yang Xm, Zhang Pf. Analysis of Differential Expressions of Long Non-coding RNAs in Nasopharyngeal Carcinoma Using Next-generation Deep Sequencing. J Cancer 2018; 9(11):1943-1950. doi:10.7150/jca.23481. https://www.jcancer.org/v09p1943.htm
Background: Little knowledge about long non-coding RNAs(lncRNAs) in nasopharyngeal carcinoma (NPC) has been acquired.
Methods: Next-generation sequencing was applied in 7 cases of NPC tissues and 7 cases of normal tissues in nasopharynx. PLEX, CNCI and CPAT soft-wares were used to predict novel lncRNAs. Real-time Quantitative PCR (qPCR) further validated the data in 20 cases of NPC tissues and 14 cases of normal tissues. Then the cis-regulators and trans-regulators and potential biological functions together with pathways were predicted by Bioinformatics.
Results: Totally, 4248 novel lncRNAs were found to be expressed in our samples. And 2192 lncRNAs and 23342 mRNAs were considered to be differentially expressed in NPC. Among the results, 306 lncRNAs and 4599 mRNAs were significantly up-regulated, whereas 204 lncRNAs and 2059 mRNAs were significantly down-regulated, respectively. Moreover, 62 lncRNAs trans-regulated genes were involved in Epstein-Barr virus (EBV) infection pathway in our study. Jun proto-oncogene (JUN), which was related to a cis-regulator lncRNA RP4-794H19.1, was enriched in cancers and involved in Tumor Necrosis Factor (TNF) signaling pathway, might play a key role in NPC.
Conclusion: These findings broadened the lncRNAs landscape of NPC tissues and shed light on the roles of these lncRNAs, which might be conducive to the comprehensive management of NPC.
Li, X.x., liang, X.j., Zhou, L.y., Liu, R.j., Bi, W., Zhang, S., Li, S.s., Yang, W.h., Chen, Z.c., Yang, X.m., Zhang, P.f. (2018). Analysis of Differential Expressions of Long Non-coding RNAs in Nasopharyngeal Carcinoma Using Next-generation Deep Sequencing. Journal of Cancer, 9(11), 1943-1950. https://doi.org/10.7150/jca.23481.
ACS
Li, X.x.; liang, X.j.; Zhou, L.y.; Liu, R.j.; Bi, W.; Zhang, S.; Li, S.s.; Yang, W.h.; Chen, Z.c.; Yang, X.m.; Zhang, P.f. Analysis of Differential Expressions of Long Non-coding RNAs in Nasopharyngeal Carcinoma Using Next-generation Deep Sequencing. J. Cancer 2018, 9 (11), 1943-1950. DOI: 10.7150/jca.23481.
NLM
Li Xx, liang Xj, Zhou Ly, Liu Rj, Bi W, Zhang S, Li Ss, Yang Wh, Chen Zc, Yang Xm, Zhang Pf. Analysis of Differential Expressions of Long Non-coding RNAs in Nasopharyngeal Carcinoma Using Next-generation Deep Sequencing. J Cancer 2018; 9(11):1943-1950. doi:10.7150/jca.23481. https://www.jcancer.org/v09p1943.htm
CSE
Li Xx, liang Xj, Zhou Ly, Liu Rj, Bi W, Zhang S, Li Ss, Yang Wh, Chen Zc, Yang Xm, Zhang Pf. 2018. Analysis of Differential Expressions of Long Non-coding RNAs in Nasopharyngeal Carcinoma Using Next-generation Deep Sequencing. J Cancer. 9(11):1943-1950.
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.